Pharmacodynamic evaluation of clopidogrel reloading vs. switching to prasugrel or ticagrelor in clopidogrel resistant Indian patients
Clinical Trials and Regulatory Science in Cardiology · 2016
DOI: 10.1016/j.ctrsc.2015.10.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Trials and Regulatory Science in Cardiology, 2016. Verfasst von Sandeep Khasa und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Khasa, S., Khanna, R., Ashfaq, F., & Goel, P. K. (2016). Pharmacodynamic evaluation of clopidogrel reloading vs. switching to prasugrel or ticagrelor in clopidogrel resistant Indian patients. Clinical Trials and Regulatory Science in Cardiology. https://doi.org/10.1016/j.ctrsc.2015.10.007
Vancouver
Khasa S, Khanna R, Ashfaq F, Goel PK. Pharmacodynamic evaluation of clopidogrel reloading vs. switching to prasugrel or ticagrelor in clopidogrel resistant Indian patients. Clinical Trials and Regulatory Science in Cardiology. 2016. doi:10.1016/j.ctrsc.2015.10.007
BibTeX
@article{Khasa2016,
author = {Khasa, Sandeep and Khanna, Roopali and Ashfaq, Fauzia and Goel, Pravin K.},
title = {Pharmacodynamic evaluation of clopidogrel reloading vs. switching to prasugrel or ticagrelor in clopidogrel resistant Indian patients},
journal = {Clinical Trials and Regulatory Science in Cardiology},
year = {2016},
doi = {10.1016/j.ctrsc.2015.10.007}
}
EUVIMED